Thread by @MadAboutStocks_

Dr. Velumani onboard with 5% .

Aditya Puri inducted into the board and my guess will me made Chairman soon .

Founder( Siddharth Shah’s ) parents have tasted failure & succeeded.

FY22 Revenue : 6500 Cr.

Peak of Pessimism priced in ? Mostly.

#UL2

IPO only when it’s just 3-6 months away from hitting EBITDA Positive .

This one is a B2B + B2C + B2B2C bet .

Also it’s Diagnostics arm is smartly playing the Tier 3 & Tier 4 - BHARAT 🇮🇳 theme .

#Thyrocare #Pharmeasy

My Scuttlebutt revealed peak of TECH employee firing done by last December . Now realistic numbers have settled in .

Definitely 2022 has been a year of reevaluation ( maybe all thanks to Zomato, Nykaa & PolicyBazaars of the world)

$9 BN. to $6 BN. to where ? 😃

Ending this short note on #Pharmeasy with this OCT 2022 snippet from the Founder - Siddharth and you can clearly see ADITYA PURI is at work 😎

P.S : TEMASEK, TPG , EVERMED , GOLDMAN SACHS and a host of other marquee names continue to have faith on #PharmEasy .

Not saying they can’t be wrong , but they have loads of information that retail isn’t privy to 😄

Between founders (7%) & Management (6%) , still 13% is the stake . While low , you cannot look at Tech Disruptors to have traditional Promoter stake of 50% +

What’s pleasing tough is there are as many as 43 investors holding about 70% of the company. Naspers at 12% is No.1

Of all the aspects what I liked the most was Siddharth Shah - who admits that he FAILED FANTASTICALLY initially and how then he got to have his others Founders onboarded ( most of them his friends ) .

This IIM Ahmedabad alum is what new age Indian Entrepreneurs are all about 🎯

I am very bad with predications but let me still put one for the record .

Early 2025 / Late 2024 is when we will see the IPO .

Today the stock is priced 21.5 .

Strictly NO RECOMMENDATION 🙏

Have a great Sunday ! And if you liked this thread 🧵, do share ahead ⚡️⚡️